Prognostic Value of Inflammation and Nutrition-Based Scores in Non-Small Cell Lung Cancer

• Published in: Medical principles and practice Vol. 33; no. 2; pp. 122 - 132
• Main Authors: Erciyestepe, Mert, Selvi, Oğuzhan, Dinç Sonuşen, Şermin, Öztürk, Ahmet Emin, Dinç, Gülhan, Güneş, Tuğçe Kübra, Aydın, Okan, Yaşar, Nurgül, Balkaya Aykut, Gözde, Vatansever, Sezai
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland S. Karger AG 01.04.2024
• Subjects: Adult; Aged; Aged, 80 and over; Body mass index; Cancer therapies; Carcinoma, Non-Small-Cell Lung - mortality; Carcinoma, Non-Small-Cell Lung - pathology; Chemotherapy; Disease Progression; Female; Humans; Immunotherapy; Inflammation; Lung cancer; Lung Neoplasms - mortality; Lung Neoplasms - pathology; Lymphatic system; Lymphocyte Count; Lymphocytes; Male; Medical prognosis; Metastasis; Middle Aged; Monoclonal antibodies; Mortality; Neutrophils; Nutrition; Nutrition Assessment; Nutritional Status; Oncology; Original Paper; Platelet Count; Prognosis; Proteins; Retrospective Studies; Statistical analysis; Platelet-to-lymphocyte ratio; Prognostic nutritional index; Modified Glasgow prognostic score; Neutrophil-to-lymphocyte ratio; Non-small cell lung cancer

Abstract Objective: In studies conducted on non-small cell lung cancer (NSCLC) patients, many factors such as age, stage, weight loss, lymph node, and pleural involvement have been shown to affect survival. On the other hand, systemic inflammation plays a critical role in proliferation, migration, i...